You are here: Home » Companies » Results
Aditya Birla Capital posts highest ever consolidated net at Rs 289 cr
Parag Milk Foods third quarter net profit dips 59% to Rs 11.21 crore
Business Standard

GlaxoSmithKline Pharmaceuticals reports net profit of Rs 157 cr in Q3

GlaxoSmithKline Pharmaceuticals on Friday said it has registered a consolidated net profit of Rs 156.51 crore for the third quarter ended December

Topics
GlaxoSmithKline | Pharma sector | Drugmaker

Press Trust of India  |  New Delhi 



GlaxoSmithKline. Photo: Reuters
GlaxoSmithKline. Photo: Reuters

Pharmaceuticals on Friday said it has registered a consolidated net profit of Rs 156.51 crore for the third quarter ended December.

The company had reported a net loss of Rs 661.16 crore in the October-December period of 2019-20.

Revenue from operations rose by 10 per cent to Rs 857.20 crore during the third quarter as against Rs 778.59 crore in the year-ago period, the company said in a regulatory filing.

"The company demonstrated a strong rebound with sales growing by 33 per cent from first quarter of FY21 post a decline in the pandemic peak, as most of our key brands gained market share and outpaced their competitor brands," Pharmaceuticals MD Sridhar Venkatesh said.

Vaccines and respiratory segments remain important growth areas for the company and are expected to grow in higher double digits, he added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Fri, February 05 2021. 20:42 IST

RECOMMENDED FOR YOU

.